Cargando…
Long non-coding RNA ZEB1-AS1 predicts a poor prognosis and promotes cancer progression through the miR-200a/ZEB1 signaling pathway in intrahepatic cholangiocarcinoma
Emerging evidence suggests that long non-coding RNAs (lncRNAs) play pivotal roles in cancer progression, including in intrahepatic cholangiocarcinoma (IHCC). The overexpression of lncRNA ZEB1 antisense 1 (ZEB1-AS1) has been discovered in several types of cancer; however, the clinical significance an...
Autores principales: | Jiao, Mingwen, Ning, Shanglei, Chen, Jingbo, Chen, Lili, Jiao, Meng, Cui, Zhonghui, Guo, Lingyu, Mu, Wentao, Yang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170034/ https://www.ncbi.nlm.nih.gov/pubmed/32236578 http://dx.doi.org/10.3892/ijo.2020.5023 |
Ejemplares similares
-
SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018) -
ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8(+) T cell fates
por: Guan, Tianxia, et al.
Publicado: (2018) -
ZEB1 in Pancreatic Cancer
por: Wellner, Ulrich, et al.
Publicado: (2010) -
The Curious Case of ZEB1
por: Madany, Mecca, et al.
Publicado: (2018) -
Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer
por: Su, Wenjing, et al.
Publicado: (2017)